RIM
IPXL

RS Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History

RS Investment Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-809,959
Closed -$19.2M – 407
2014
Q3 		$19.2M Sell
809,959
-130,991
-14% -$3.36M 0.18% 171
2014
Q2 		$28.2M Sell
940,950
-387,487
-29% -$10.5M 0.24% 144
2014
Q1 		$35.1M Sell
1,328,437
-1,022,047
-43% -$25.5M 0.21% 146
2013
Q4 		$59.1M Sell
2,350,484
-184,414
-7% -$4.11M 0.36% 78
2013
Q3 		$52M Buy
2,534,898
+23,373
+0.9% +$483K 0.34% 88
2013
Q2 		$50.1M Buy
+2,511,525
New +$44.6M 0.36% 79

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

RS Investment Management's IPXL Position: Q4 2014 in Review

RS Investment Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2014, closing a stake of 809,959 shares — an estimated $19.2M sold.

RS Investment Management first reported a position in IPXL in Q2 2013 and held it in 6 quarters. The position peaked at $59.1M in Q4 2013. 178 funds tracked by Wall St. Rank hold IPXL as of Q4 2014.

  • RS Investment Management reported no remaining Impax Laboratories, Inc. position as of Q4 2014 after selling out during the quarter.
  • RS Investment Management sold 809,959 Impax Laboratories, Inc. shares in Q4 2014, an estimated $19.2M.
  • RS Investment Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 6 quarters.
  • RS Investment Management's Impax Laboratories, Inc. position peaked at $59.1M in Q4 2013.
  • 178 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2014.

Based on RS Investment Management's 13F filing for Q4 2014, filed 12 Feb 2015.